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Community based distribution of oral HIV self-testing kits in 
Zambia: a cluster-randomised trial nested in four HPTN 071 
(PopART) intervention communities 
Chama Mulubwa, Bernadette Hensen, Mwelwa M Phiri, Kwame Shanaube, Albertus J Schaap, Sian Floyd, Comfort R Phiri, Chiti Bwalya, 
Virginia Bond, Musonda Simwinga, Lawrence Mwenge, Sarah Fidler, Richard Hayes, Alwyn Mwinga, Helen Ayles, for the HPTN 071 (PopART) 
Study Team*
Summary
Background The HPTN 071 (PopART) cluster-randomised trial provided door-to-door HIV testing services to a large 
proportion of individuals residing in 21 intervention communities in Zambia and South Africa from 2014 to 2017 and 
reached the UNAIDS first 90 target among women in Zambia, yet gaps remained among men and young adults. This 
cluster-randomised study nested in the HPTN 071 (PopART) trial sought to increase knowledge of HIV status across 
all groups by offering the choice of oral HIV self-testing in addition to routine door-to-door HIV testing services.
Methods We nested this cluster-randomised trial in four HTPN 071 (PopART) intervention communities in northern 
Zambia. 66 zones (clusters) in these communities were randomly allocated (1:1) to either oral HIV self-testing plus 
routine door-to-door HIV testing services (HIV self-testing group) or the PopART standard of care of door-to-door 
HIV testing services alone (non- HIV self-testing group) over a 3-month period. All individuals aged 16 years or older 
were eligible for HIV testing. Randomisation was achieved by randomly selecting one allocation from a list of 10 000 
possible allocations during a public ceremony. In HIV self-testing zones, trained lay-counsellors (known as community 
HIV care providers) visited households and offered eligible individuals the choice of HIV testing using HIV self-
testing or routine door-to-door HIV testing services. For individuals aged 18 years or older whose partner was absent 
during the household visit, an HIV self-test kit could be left for secondary distribution to the absent partner. The 
primary outcome was knowledge of HIV status (defined as self-reporting HIV positive to the community HIV care 
providers or accepting an offer of HIV testing services). Outcomes were measured among households that were first 
visited, and individuals first enumerated as a household member during the HIV self-testing intervention period. We 
analysed data at the individual level using population-average logistic regression models, accounting for clustering of 
outcomes by zone, to estimate the effect of the intervention. This trial is registered with ClinicalTrials.gov, number 
NCT02994329.
Findings Between Feb 1, and April 30, 2017, the community HIV care providers enumerated 13 267 eligible individuals 
in the HIV self-testing group and 13 706 in the non-HIV self-testing group. After intervention implementation, 
9027 (68%) of 13 267 in the HIV self-testing group had knowledge of HIV status compared with 8952 (65%) of 13 706 
in the non-HIV self-testing group (adjusted odds ratio 1·30, 95% CI 1·03–1·65; p=0·03). The effect differed by sex 
(pinteraction=0·01). Among men, knowledge of HIV status was higher in the HIV self-testing group than in the non-HIV 
self-testing group (3843 [60%] of 6368 vs 3571 [55%] of 6486; adjusted odds ratio 1·31, 95% CI 1·07–1·60; p=0·01). 
There was no evidence of a between-group difference among female participants.
Interpretation Providing a choice of HIV self-testing during delivery of door-to-door HIV testing services increased 
knowledge of HIV status, driven by an effect among men. Lay counsellors have a vital role to play in adapting HIV 
self-testing interventions to local context.
Funding The International Initiative for Impact Evaluation (3ie), the Bill & Melinda Gates Foundation, National 
Institute of Allergy and Infectious Diseases, National Institute on Drug Abuse, National Institute of Mental Health, 
and the President’s Emergency Plan for AIDS Relief.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Despite widespread availability of facility-based and 
community-based HIV testing services, an estimated 
30% of all people living with HIV are unaware of their 
HIV-positive status.1 Furthermore, since 2010, the 
number of global new adult HIV infections has remained 
stable at around 1·9 million per year.2 Increasing 
coverage of HIV prevention services requires novel 
strategies to deliver HIV testing services and reach 
individuals who remain unaware of their HIV status.3 In 
Zambia, coverage of HIV testing services has increased 
substantially since 2007,4–6 yet there remain gaps. In 
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2013–14, 46% of women were tested and received the test 
result within the previous 12 months compared with 
37% of men.6 During 2015–16, 70% of HIV-positive 
women knew their HIV-positive status compared with 
63% of men.5,6 Furthermore, adults older than 24 years 
are more likely to have tested than adolescents and young 
people aged 15–24 years.6,7
HPTN 071 (PopART) is a cluster-randomised trial 
ongoing in 21 communities in South Africa and Zambia 
to estimate the effect of universal HIV testing and 
immediate treatment on HIV incidence.8 After 
one round of door-to-door delivery of HIV testing 
services in the PopART intervention communities in 
Zambia, the first 90 of the UNAIDS 90-90-90 targets 
was nearly reached among women, but among men 
coverage was approximately 10–15% below target.9 
PopART has shown that, even with intensive household 
delivery of HIV testing and related services, challenges 
remain in reaching the ambitious first and second 90s 
of the UNAIDS 90-90-90 targets, particularly among 
men.9
HIV self-testing is a novel strategy that has the 
potential to reach individuals underserved by currently 
available HIV testing strategies.10 A systematic review11 
showed that HIV self-testing is feasible for populations 
in high HIV-prevalence settings. Since 2016, WHO has 
recom mended evidence-based approaches to delivering 
HIV self-testing services to reach men and other key 
popu lations.12 Evidence from Malawi and Kenya sug-
gests that oral HIV self-testing is acceptable and 
accurate, and can potentially increase community levels 
of HIV testing and promote male partner testing.11,13 
Although feasible and acceptable, there remains a need 
for evidence of how to deliver HIV self-testing services 
to increase knowledge of HIV status, particularly 
among men and younger adults.
Here, we report results from a cluster-randomised trial 
of HIV self-testing services nested within the HPTN 071 
(PopART) trial. The nested trial offered an opportunity to 
evaluate whether the door-to-door offer of the option of 
oral HIV self-testing alongside the offer of home-based 
finger-prick rapid diagnostic testing (finger-prick RDT) 
Research in context
Evidence before this study
We searched PubMed and Medline for English-language 
publications on studies of strategies to increase HIV testing 
uptake through distribution of HIV self-tests published through 
to Sept 14, 2017. We used the search terms self-test* AND HIV 
infections AND Africa. Of the studies identified, many explored 
the acceptability and accuracy of HIV self-testing in Kenya, 
Malawi, and South Africa. These studies consistently reported 
that HIV self-testing is acceptable, and in Malawi is the 
preferred option for future HIV testing. Studies exploring the 
distribution of HIV self-tests included two studies to promote 
male partner HIV testing: a cohort study of secondary 
distribution by HIV-negative female sex workers and women 
receiving antenatal care in Kenya, and a trial of secondary 
distribution by women receiving HIV self-tests through 
antenatal care or postpartum care in Kenya. In the cohort study, 
a large proportion of the women receiving an HIV self-test 
distributed these to their sexual partners. In the trial, partner 
HIV testing was higher in the HIV self-test group than in the 
group offered an invitation for male partners to attend 
clinic-based HIV testing. In Malawi, a community-based study 
of HIV self-test distribution showed high uptake and 
acceptability of HIV self-tests delivered by volunteer 
counsellors. We found little evidence of rigorous, randomised, 
controlled trials of strategies to distribute HIV self-tests. 
Further, there was little available evidence of secondary 
distribution of HIV self-tests outside of facility settings.
Added value of this study
This cluster randomised trial provided rigorous evidence that a 
3-month intervention of door-to-door distribution of HIV 
self-tests increased knowledge of HIV status among adults aged 
16 years and older. This effect was driven by increased 
knowledge of HIV status among men and young adults aged 
16–29 years, with no between-group differences noted in 
women. This was the first trial to show that community-based 
door-to-door secondary distribution of HIV tests can increase 
HIV testing among individuals, primarily men, who are not at 
home during household visits from lay counsellors. Among men 
aged 30 years or more who HIV self-tested, more than a 
third self-tested through unsupervised HIV self-testing or 
secondary distribution of HIV self-tests. The trial also showed 
that the door-to-door distribution of HIV self-tests increased 
knowledge of HIV status among community residents whose 
HIV status was not known to lay counsellors despite 2 years of 
household delivery of HIV-related services, including HIV testing.
Implications of all the available evidence
Our findings suggest that the door-to-door distribution of HIV 
self-tests increases knowledge of HIV status among individuals 
who are underserved by currently available HIV testing services. 
Secondary distribution of HIV self-tests through this strategy 
was acceptable and might dentify a higher proportion of 
individuals testing HIV positive. Future research should explore 
targeted secondary distribution of HIV self-tests to partners of 
HIV-positive individuals to support reaching individuals at 
highest risk of infection. The door-to-door distribution of HIV 
self-tests is a promising strategy that complements currently 
available HIV testing strategies by accessing so-called harder to 
reach individuals, including men. Door-to-door secondary 
distribution of HIV self-tests in high-prevalence settings could 
support reaching older men, who are more likely to be HIV 
positive than younger men, and linking them to prevention or 
treatment services, and reach HIV Prevention 2020 targets.
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by lay counsellors increased current knowledge of HIV 
status among the general adult and adolescent population 
in four urban communities in Zambia.
Methods 
Study design and participants
We nested this HIV self-testing cluster-randomised trial 
in four urban communities in two northern provinces of 
Zambia (figure 1).8 Details of the HPTN 071 (PopART) 
trial are reported elsewhere.8 Briefly, this is a cluster-
random ised trial done in 21 communities in Zambia and 
South Africa to estimate the effect of a household 
combination HIV prevention package (PopART 
intervention), which includes the door-to-door offer of 
HIV testing services (finger-prick RDT), immediate 
treatment for HIV-positive individuals regardless of CD4 
cell count, and promotion of male circumcision for HIV-
negative men, on HIV incidence.8 Community HIV care 
providers did annual rounds within a defined geo-
graphical area (called a zone), during which they attempt 
to visit all households, enumerate all household 
members, and offer the PopART intervention services to 
all individuals, regardless of previous participation in 
previous rounds. Throughout an annual round, 
community HIV care providers return to households to 
offer HIV testing services to individuals absent at the 
first household visit, and support linkage to and retention 
in care for individuals testing HIV-positive.8 At the time 
of the HIV self-testing study, the community HIV care 
providers were doing their third PopART annual round.8
During household visits, data on household enumer-
ation, consent to participate in PopART, and uptake of 
HIV testing services and other PopART services are 
collected by community HIV care providers using 
electronic data capture devices. The four HIV self-testing 
trial communities were PopART intervention com-
munities selected by the study team to reflect the range 
and pattern of uptake of HIV testing services in the 
other PopART intervention communities. Each 
community had one public health facility, situated a 
maximum of 1·93–3·67 km from households. Each 
community had been divided into zones (clusters) that 
comprised approximately 450–500 households, with an 
estimated average popu lation of approximately 
1400 individuals aged at least 16 years per zone. There 
were 66 zones across the communities, with an 
estimated total population of around 90 000 individuals 
aged at least 16 years. A pair of com munity HIV care 
providers managed each zone.
All adolescents and adults aged 16 years and older 
and resident in the 66 zones were eligible to participate 
in the HIV self-testing study. During the HIV self-
testing study implementation period of approximately 
3 months, individuals at home during community HIV 
care providers’ household visits were asked for verbal 
consent to participate in PopART. If the individual 
Figure 1: Map showing the randomised zones and location of 12 PopART clusters in Zambia, 2013
Blue areas are zones randomly allocated to the HIV self-testing intervention. Red cross indicates location of the health facility within the community. Black closed circles 
are towns. Red triangles are HPTN 071 (PopART) communities. Grey areas are PopART districts. Green areas are provinces.
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consented and did not report an HIV-positive status, 
they were eligible for an offer of HIV testing services.
The study was approved by the University of Zambia 
Biomedical Research Ethics Committee and London 
School of Hygiene and Tropical Medicine ethics 
committee. Permission to do the study was also granted by 
the Division of AIDS at the National Institutes of Health 
(MD, USA), the Zambia National Health Research 
Authority, and the Zambia Medicines Regulatory Authority.
Randomisation and masking
The 66 zones were randomly assigned (1:1) to either oral 
HIV self-testing plus the PopART standard of care 
of routine door-to-door HIV testing services (HIV 
self-testing group) or door-to-door HIV testing services 
alone (non-HIV self-testing group) over a 3-month 
period. To achieve balance across clusters in factors that 
were likely to affect the primary outcome, we stratified 
randomisation by community.14 We also restricted the 
randomisation, first within each community and second 
across all four communities, to achieve balance by trial 
group on average values of key outcomes measured 
during round 2, including: the percentage of adults 
whose HIV status was known to the community HIV 
care providers by the end of round 2; the percentage 
accepting the offer of HIV-testing among those eligible to 
test in round 2, overall and separately for men, women, 
adults aged 18–29 years, and those resident in rounds 1 
and 2; the percent age of men not contacted during 
round 2, and the average number of adults per zone. SF 
generated the randomisation protocol and, from several 
billion possible allocations that met restriction criteria, 
drew a computer-generated random sample from 
combinations of 10 000 possible allocations.
In December, 2016, we held a randomisation ceremony 
with community HIV care providers, their supervisors, 
and members of the PopART community advisory 
boards to allocate the zones to the HIV self-testing 
or non-HIV self-testing groups. Using the randomly 
selected list of allocations numbered from 0000 to 9999, 
four individuals selected four numbered balls from a 
bag. This four-digit number corresponded to an allocation 
number in the list of 10 000, and determined, for each 
zone, whether it was to be allocated to group 0 or 1. In a 
second stage, a similar process was used to randomly 
assign the zones numbered 0 and 1 to either the HIV 
self-testing or non-HIV self-testing groups (figure 1). As 
a cluster-randomised trial of a strategy to deliver HIV 
self-testing services to all households within a cluster, 
blinding of participants and community HIV care 
providers was not feasible.
Procedures
The intervention was implemented between 18 Jan, 
and 30 April, 2017. The first 2 weeks of implementation 
were considered a priori pre-full-implementation weeks. 
As such, the evaluation period was from Feb 1, to 
April 30, 2017. In zones randomised to the HIV self-
testing intervention, individuals contacted during com-
munity HIV care providers household visits who 
con sented to participate in PopART and were eligible for 
HIV testing were offered a choice of using oral HIV self-
testing or a finger-prick sampling of whole blood and 
rapid HIV testing (finger-prick RDT). This was done 
according to PopART procedures and the Zambian 
national HIV testing algorithm, using Alere Determine 
HIV-1/2 (Chiba, Japan) as the screening test and Uni-
Gold HIV test (ref 1206502, Trinity Biotech, Ireland) as 
the confirmatory test. For individuals choosing HIV self-
testing, community HIV care pro viders demonstrated 
how to do the self-test and read the result. Because HIV 
self-testing was a novel procedure in the 
four communities, individuals were offered either super-
vised (in the presence of a community HIV care 
provider) or un supervised (in the absence of a 
community HIV care provider) HIV self-testing. The 
level of super vision and support provided was dependent 
on individual preference. Individuals opting for HIV 
self-testing were given a package consisting of the 
OraQuick self-test kit (Bangkok, Thailand),15 user-
friendly pictorial instructions for use provided by the 
manu facturer (translated into local languages), a card 
with the community HIV care provider’s phone number, 
a self-complete results form, and an envelope for 
returning the used self-test. 
Individuals aged 18 years or older with a partner 
living in the same household but absent at the time of 
the community HIV care provider’s visit were offered 
an HIV self-test kit for their absent partner. Individuals 
accepting an HIV self-test kit for secondary distribution 
were asked to sign an agreement stating that the kit 
would only be given to the intended individual, that the 
individual would not be coerced into using the HIV 
self-test kit, and that the information required for the 
individual to use the HIV self-test kit would be 
communicated to them. The community HIV care 
provider left a card with their phone number to allow 
the absent individual to contact them should additional 
support be required and for linkage to services, 
including confirmatory testing.
For individuals choosing unsupervised HIV self-testing 
or where an HIV self-test kit was left for an absent 
partner, community HIV care providers did a follow-up 
visit within 7 days to verify use and offer follow-up 
services. Individuals also had the option of returning the 
HIV self-test package to the clinic. During follow-up 
visits, community HIV care providers collected HIV self-
test kits and self-completed results forms where available. 
The community HIV care providers also attempted to 
meet individuals who received an HIV self-test kit via 
their partner. Individuals whose HIV self-test results 
were recorded in their absence were considered to have 
participated in the PopART intervention in round 3. 
Where the HIV self-test kit was available, the community 
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HIV care providers checked the results of the test, and 
for individuals who they met in person and whose HIV 
self-test result was reactive, they offered confirmatory 
HIV testing using parallel testing with the same rapid 
diagnostic tests as HIV finger-prick RDT. Post-test 
counselling was provided, and HIV-positive individuals 
were referred to treatment and care irrespective of 
whether they accepted the offer of confirmatory testing. 
HIV-negative individuals were counselled and referred to 
HIV prevention services. Individuals who were left an 
HIV self-test kit during the intervention period were 
followed up until Sept 30, 2017 to provide support on 
doing the HIV self-testing, confirmatory testing, and 
linking to services as required.
Zones randomised to the non-HIV self-testing group 
continued to receive the standard PopART combination 
package of interventions, including the offer of home-
based HIV finger-prick RDT. For individuals testing 
HIV positive, community HIV care providers provided 
post-test counselling, and referral to HIV treatment 
and care services. HIV-negative individuals were 
counselled and referred to HIV prevention services.
Outcomes
The primary outcome was current knowledge of HIV 
status, defined as an individual self-reporting knowing 
their HIV-positive status to a community HIV care 
provider, or accepting an offer of either HIV self-testing 
or finger-prick RDT and the HIV test result was recorded 
by community HIV care providers. Where an HIV self-
test kit was distributed for secondary use, the test was 
recorded as used if the index individual reported the 
result to the community HIV care provider or the 
intended user of the HIV self-test kit later met the 
community HIV care provider and reported that they had 
used the test. We measured the outcome among 
households that were first visited in round 3 between 
Feb 1, and April 30, 2017, restricted to individual 
household members aged 16 years or older who were 
first enumerated or (re-)enumerated as a household 
member during this period. Information on outcomes 
used data collected from household visits, and re-visits 
(where an HIV self-test kit was left for unsupervised or a 
secondary distribution), done between Feb 1, and 
June 30, 2017. Individuals aged 16 years or older 
enumerated as a household member but not seen by the 
community HIV care provider during the study period 
were assumed not to know their HIV status in round 3.
Secondary outcomes were consent to participate in 
PopART; uptake of HIV testing services among individuals 
who consented to PopART and were eligible for an offer of 
HIV-testing services; linkage to confirmatory testing in 
the HIV self-testing group; programmatic costs and 
incremental cost-effectiveness of adding HIV self-testing 
to the PopART inter vention; and qualitatively describing 
HIV self-test kit distribution and social harms. Social 
harms were iden tified during observations of HIV self-test 
kit distribution and through community engagement 
mechanisms, such as stakeholder and community 
advisory board meetings, and were categorised between 
incidents related or unrelated to the study and between 
serious and non-serious incidents. In this Article, we 
describe only social harms reported during the study 
period. Further analysis on secondary distri bution and 
linkage to confirmatory testing is ongoing and will be 
reported elsewhere.
We did sensitivity analyses of the primary outcome to 
include individuals whose HIV-positive status was known 
to the community HIV care provider in round 1 or round 2 
(or both) of PopART, who were enumerated during the 
3-month implementation phase of this trial, but who did 
not participate, either because they were absent or they 
did not consent to PopART.
Statistical analysis
The study was powered to show an overall reduction of 
5% in the percentage of adults who did not know their 
HIV status in the HIV self-testing group compared with 
the non-HIV self-testing group, assuming that the 
percentage who did not know their HIV status in the 
non-HIV self-testing group was in the range 35–40%. 
Study power was greater than 90% if the between-zone 
coefficient of variation k was 0·15, and around 70–80% if 
k was 0·20, assuming an average of approximately 
400 adults enumerated per zone. For subgroup analyses 
by sex, study power was in the range of around 60–90% 
to show a 5% reduction in the percentage of individuals 
who did not know their HIV status in the HIV self-
testing group, assuming that the percentage who did not 
know their HIV status in the non-HIV self-testing group 
was in the range 30–45% and that k was 0·2.
To estimate the effect of the HIV self-testing 
intervention, we analysed data at the individual level, 
using population-average logistic regression models to 
account for clustering by zone, to adjust for community 
to explain some of the between-zone variation, and a 
priori for age group and sex. Prespecified sub-group 
analyses for the primary and secondary outcomes 
included analyses by sex, age (individuals aged 
16–29 years, adults aged ≥30 years), and individuals who 
were resident during rounds 1 and 2 of PopART but who 
did not participate in either round. We analysed the data 
with Stata version 15.0.
We did a prospective economic evaluation, from the 
provider’s perspective, to comparatively calculate unit 
costs of HIV testing services in both groups and calculated 
the incremental cost of delivering HIV testing services in 
the HIV self-testing group. Full annual financial and 
economic costs were calculated. Financial costs included 
all expenditures for resources in both groups, whereas 
economic costs captured the full value of all resources 
used to deliver HIV testing services in both groups, 
including the valuation of donated goods or services and 
individual time to deliver services.16 Cost inputs included 
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equipment, HIV testing supplies, general supplies, 
transportation and travel, administration, and personnel 
resources (appendix p 3). In this analysis, we used landed 
costs of US$3·00 per HIV self-test kit, which accounted 
for purchase, shipment, and landing taxes. Resource use 
data were collected between Dec 1, 2016, and June 30, 2017. 
Costs were adjusted to 2017 US$ using an assumed 
exchange rate of ZMW 9·50.
Data sources included financial records, the community 
HIV care provider’s electronic data capture device, and 
interviews with the HIV self-testing intervention team. In 
the cost analysis, we calculated the total cost of imple-
menting HIV testing service activities, and cost per person 
who was: enumerated, tested, and newly diag nosed HIV 
positive for both groups.
Role of the funding source
The International Initiative for Impact Evaluation (3ie) 
reviewed and provided non-binding comments on the 
draft manuscript before submission. The other funders 
of the study had no role in study design, data collection, 
data analysis, data interpretation, or writing of the report. 
All authors had final responsibility for the decision to 
submit for publication.
Results
Between Feb 1, and April 30, 2017, the community HIV 
care providers enumerated 13 267 eligible individuals in 
the HIV self-testing group and 13 706 in the non-HIV 
self-testing group (table 1, figure 2). In both groups, 
half the individuals were aged 16–29 years, and a 
similar pro portion were absent during the community 
HIV care provider’s household visit (table 1).
After the intervention period, 9027 (68%) of 13 267 in 
the HIV self-testing group knew their HIV status 
compared with 8952 (65%) of 13 706 individuals in the 
non-HIV self-testing group (adjusted odds ratio [OR] 
1·30, 95% CI 1·03–1·65; p=0·03; table 2).
There was evidence that the effect of the intervention 
differed by sex (pinteraction=0·01). Among men, knowledge 
of HIV status was higher in the HIV self-testing group 
than in the non-HIV self-testing group whereas among 
women, knowledge of HIV status did not differ between 
groups (table 2). The effect did not seem to differ by age 
group (p interaction=0·44), but more adults aged 16–29 years 
and 30 years or older in the HIV self-testing group knew 
their HIV status compared with the non-HIV self-testing 
group (table 2).
Similarly, among individuals who were resident during 
PopART rounds 1 and 2, but did not participate in either 
round, a greater number in the HIV self-testing group 
had knowledge of their HIV status compared with the 
non-HIV self-testing group (table 2).
Stratified by age and sex, knowledge of HIV status was 
higher in the HIV self-testing group than in the non-HIV 
self-testing group among younger and older men, men 
who were resident during PopART rounds 1 and 2 but 
who did not participate in either round, and men who 
partici pated in previous rounds of PopART but declined 
HIV testing (table 3). There was weak evidence that the 
intervention had an effect among the small number of 
women resident in PopART rounds 1 and 2 but who did 
not participate in either round, with little evidence of an 
effect among women who participated in previous 
rounds of PopART but declined HIV testing (table 3).
In a sensitivity analysis, including individuals whose 
HIV-positive status was known to community HIV care 
providers in PopART rounds 1 or 2, or both, but who had 
not participated in this HIV self-testing trial, 9179 (69%) 
of 13 267 knew their HIV status in the HIV self-testing 
group compared with 9079 (66%) of 13 706 in the non-
HIV self-testing group (adjusted OR 1·34, 95% CI 
1·07–1·69; p=0·01). Among men, 3910 (61%) of 6368 
knew their HIV status in the HIV self-testing group 
compared with 3622 (56%) of 6486 in the non-HIV self-
testing group (adjusted OR 1·34, 95% CI 1·10–1.64, 
p=0·004). After accounting for variation explained by 
differences among the four communities and the effect 
of the HIV self-testing intervention, the between-zone 
coefficient of variation (k) for the percentage of 
individuals who did not know their HIV status by the end 
of this trial was 0·23.
Participation in PopART was slightly higher in the HIV 
self-testing group, with 10 290 (78%) of 13 267 enumerated, 
either because they were contacted and consented to 
participate, or because they self-tested through secondary 
See Online for appendix
HIV 
self-testing 
(n=13 267)
Non-HIV 
self-testing 
(n=13 706)
Male sex 6368 (48%) 6486 (47%)
Age group (years)
16–19 2176 (16%) 2190 (16%)
20–24 2653 (20%) 2804 (21%)
25–29 1940 (15%) 2008 (15%)
30–34 1651 (12%) 1641 (12%)
35–44 2355 (18%) 2345 (17%)
≥45 2492 (19%) 2718 (20%)
Absent during community HIV care-provider’s visit
Total 2782 (21%) 3018 (22%)
Men 1942 (70%) 2140 (71%)
Women 840 (30%) 878 (29%)
Self-reported HIV positive (percentage of 
those present)
950 (9%) 1152 (11%)
Eligible for HIV testing 9340 (91%) 9304 (89%)
Previously participated in PopART (in 
same community HIV care-provider zone)
8093 (61%) 8745 (64%)
Previously resident in PopART annual 
rounds 1 or 2 (in same community HIV 
care-provider zone)
9376 (71%) 9946 (73%)
Data are n (%). The HIV self-testing group received oral HIV self-testing plus routine 
door-to-door HIV testing. The non-HIV self-testing group received only routine 
door-to-door HIV testing.
Table 1: Baseline characteristics of the study population
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distribution and their results were reported to and recorded 
by the community HIV care providers. In the non-HIV self-
testing group, 10 456 (76%) of 13 706 enumerated individuals 
participated in PopART (adjusted OR 1·40, 95% CI 
0·98–1·99; p=0·06). Stratified by sex, more men in the 
HIV self-testing group than in the non-HIV self-testing 
group participated in PopART, but there were no between-
group differences in women (table 4). By sex and age, there 
was little evidence of an effect among women of either age 
group, or among men aged 16–29 years.
The intervention increased acceptance of an offer of 
HIV testing services among men but not women (table 4, 
Figure 2: Enumeration and uptake of HIV testing in the HIV self-test and non-HIV self-test groups
Pending refers to individuals who made appointments but were not yet seen by a community HIV care provider as of June 30, 2017. *3/323 individuals were identified as knowing their HIV positive 
status before self-testing in the absence of the community HIV care provider after they were subsequently contacted in PopART annual round 3.
204 HIV 
positive 
7596 HIV 
negative
109 HIV 
positive
3618 HIV 
negative
18 HIV 
positive 
3727 supervised
4238 tested using oral 
HIV self test
7800 eligible and 
tested
3519 tested using HIV 
finger-prick test
9020 eligible for 
testing
947 known HIV 
positive
1152 known HIV 
positive
9304 eligible for 
testing
9967 seen initially10 456 participated 323* (283 males, 40 females) not seen by 
community HIV care provider at first 
household visit but collected HIV 
self-test kits through partner 
1263 eligible but 
did not test
511 unsupervised
89 HIV positive 3430 HIV negative
242 results via partner 81 results in person
493 HIV 
negative
13 HIV positive 229 HIV 
negative
8 HIV positive 73 HIV 
negative
2782 absent
195 refused or pending
3018 absent
232 refused or pending
13 706 individuals enumerated 13 267 individuals enumerated
33 clusters assigned to non-HIV 
self-testing group
66 clusters randomly assigned to a study group
4 communities selected from 8 PopART communities
Community A (10 clusters) Community B (20 clusters) Community C (20 clusters) Community D (16 clusters)
33 clusters assigned to HIV 
self-testing group
1504 eligible but 
did not test
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appendix pp 5, 6). The effect was similar among young 
men aged 16–29 years and men aged 30 years and older. 
There were no between-group differences in accepting 
HIV testing services in either men or women who were 
previously resident in PopART rounds 1 and 2 but did 
not participate in either round. Among men who 
participated in previous rounds of PopART but declined 
HIV testing, HIV testing uptake was greater in the HIV 
self-testing group (table 4). There was no evidence of an 
effect among women (table 4).
Among individuals who opted for HIV self-testing in 
the HIV self-testing group, most chose supervised HIV 
self-testing, with the number of supervised HIV self-tests 
higher in women than men (appendix p 2). Among 
women, the method of HIV self-testing differed little by 
age group (appendix p 2). Among men, the type of HIV 
self-testing differed by age: 325 (38%) of 847 men aged 
30 years and older who self-tested used unsupervised or 
secondary distribution HIV self-test kits, compared with 
199 (17%) of 1161 men aged 16–29 years (p=0·004). 
Among the 148 individuals whose first HIV self-testing 
result was reactive (figure 2), seven (5%) subsequently 
reported they had known they were HIV positive before 
self-testing, and three (2%) who had tested via secondary 
distribution subsequently did a repeat HIV self-testing 
after meeting the community HIV care providers and the 
test result was negative. Of the remaining 138 who were 
eligible for confirmatory HIV testing, 105 (76%) linked to 
confirmatory testing, of whom 102 (97%) were confirmed 
HIV positive.
The total cost of delivering HIV testing services was 
US$243 745 in the HIV self-testing group and US$172 069 
in the non-HIV self-testing group. Personnel costs 
formed the largest proportion of the total costs in both 
groups followed by testing supplies, with the remaining 
costs being resource inputs at less than 10% in each 
group (appendix p 4). HIV self-testing activities accounted 
for $84 135 (35%) of the $243 745 cost of implementing 
HIV testing services in the HIV self-testing group.
The cost per person tested in the HIV self-testing 
group was 1·37 times higher than in the non-HIV self-
testing group. The incremental costs of distributing HIV 
self-test kits door-to-door alongside routine door-to-door 
HIV testing services was estimated at $71 675·78, which 
resulted in an incremental cost per additional person 
tested of $255·98 ($71 675·78 total costs for 
280 individuals). Incremental costs per individual 
confirmed HIV self-test-positive was calculated at 
$771·88 ($84 135 total costs for 109 individuals; 
appendix p 4).
13 social harms occurred in the HIV self-testing group. 
These ranged from invasion of privacy, emotional 
distress, being deceived or forced into doing HIV testing, 
threatening violence, to actual violence, and separation of 
couples (appendix p 7). Some social harms were 
exacerbated by pre-existing conditions within a couple, 
such as alcohol abuse and a history of gender-based 
violence.
Discussion
Our findings showed that a 3-month intervention of a 
door-to-door offer of HIV self-testing as an option for HIV 
testing had small but significant effects on current 
knowledge of HIV status among the general population 
Men Women
HIV self-testing Non-HIV 
self-testing
Adjusted odds 
ratio* (95% CI)
p value HIV self-testing Non-HIV 
self-testing
Adjusted odds 
ratio* (95% CI)
p value
Overall 3843/6368 (60%) 3571/6486 (55%) 1·31 (1·07–1·60) 0·01 5184/6899 (75%) 5381/7220 (75%) 1·05 (0·86–1·30) 0·62
Young adults (age 16–29 years) 2091/3129 (67%) 1979/3233 (61%) 1·31 (1·04–1·65) 0·02 2881/3640 (79%) 2938/3769 (78%) 1·15 (0·93–1·44) 0·21
Older adults (age ≥30 years) 1752/3239 (54%) 1592/3253 (49%) 1·37 (1·10–1·72) 0·01 2303/3259 (71%) 2443/3451 (71%) 1·01 (0·80–1·27) 0·96
Resident in PopART annual rounds 1 and 2, 
but did not participate in either round
128/441 (29%) 86/427 (20%) 1·64 (1·15–2·35) 0·01 45/142 (32%) 31/140 (22%) 1·68 (1·02–2·77) 0·04
Participated in PopART annual rounds 1 or 2 
or both, but declined door-to-door HIV 
testing
282/656 (43%) 236/665 (36%) 1·47 (1·03–2·09) 0·03 318/688 (46%) 351/760 (46%) 1·05 (0·78–1·41) 0·73
Data are n/N (%). The HIV self-testing group received oral HIV self-testing plus routine door-to-door HIV testing. The non-HIV self-testing group received only routine door-to-door HIV testing. *Adjusted for sex, 
age, community, and clustering by zones.
Table 3: Knowledge of HIV status stratified by sex
HIV self-testing Non-HIV 
self-testing
Adjusted odds 
ratio* (95% CI)
p value
Overall 9027/13267 (68%) 8952/13706 (65%) 1·30 (1·03–1·65) 0·03
Men 3843/6368 (60%) 3571/6486 (55%) 1·31 (1·07–1·60) 0·01
Women 5184/6899 (75%) 5381/7220 (75%) 1·05 (0·86–1·30) 0·62
Young adults (age 16–29 years) 4972/6769 (74%) 4917/7002 (70%) 1·31 (1·05–1·63) 0·02
Older adults (≥30 years) 4055/6498 (62%) 4035/6704 (60%) 1·22 (0·98–1·52) 0·07
Resident in PopART annual 
rounds 1 and 2, but did not 
participate in either round
173/583 (30%) 117/567 (21%) 1·63 (1·15–2·31) 0·01
Participated in PopART annual 
rounds 1 or 2 or both, but declined 
door-to-door HIV testing
600/1344 (45%) 587/1425 (41%) 1·29 (0·95–1·76) 0·11
Data are n/N (%). The HIV self-testing group received oral HIV self-testing plus routine door-to-door HIV testing. 
The non-HIV self-testing group received only routine door-to-door HIV testing. *Adjusted for sex, age, community, 
and clustering by zones.
Table 2: Knowledge of HIV status
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aged 16 years or older in four communities in Zambia. 
The intervention had an overall effect among men, but 
not women, and an effect among men and women 
resident in the communities during rounds 1 and 2 of 
PopART but who did not participate in either round. 
Participation in PopART increased among men but not 
women, with an increase in HIV testing among men who 
previously declined HIV testing services and a small 
increase among women who previously declined 
participation in PopART.
In Zambia, like other southern African countries, 
men are harder to reach with HIV testing services.17 HIV 
self-testing has been proposed as a strategy to reach 
men.18,19 We found that the door-to-door offer of the HIV 
self-test option increased men’s knowledge of HIV 
status and uptake of HIV testing services. This effect 
was driven by increased acceptability of HIV self-testing 
compared with standard finger-prick RDT, and by 
secondary distri bution of HIV self-testing kits. Almost 
all individuals reached through secondary distribution 
were male, and almost half the men aged 30 years and 
older who self-tested did so through unsupervised or 
secondary distribution of HIV self-testing kits. This 
study is among the first to evaluate community-based 
secondary distribution of HIV self-test kits. The 
available evidence shows that secondary distribution is 
feasible and effective when offered to antenatal care 
attendees, postpartum women, or female sex 
workers.11,20,21 A Kenyan trial22 comparing secondary 
distribution of HIV self-test kits with an invitation for 
partners of antenatal care attendees and postpartum 
women to attend facility-based HIV-testing services 
showed that secondary distribution increased partner 
testing by 39%. Our study adds to the available evidence 
sug gesting that community-based secondary distri-
bution is effective at reaching men in communities ex-
posed to 3 years of door-to-door delivery of HIV testing 
services.
Similar to findings from a Malawian HIV study,13 in 
which 25% of individuals self-testing after 2 years of 
service promotion were aged younger than 20 years, we 
showed that the HIV self-testing intervention had small 
but significant effects on knowledge of HIV status and 
uptake of HIV testing services among younger indi-
viduals aged 16–29 years.23,24 HIV incidence is high among 
adolescents and young people, particu larly among 
females aged 15–24 years who are at highest risk of HIV 
in sub-Saharan Africa.2 Adolescents and young people, 
particularly younger men, are harder to reach with HIV 
services, and less likely to be engaged in all steps of the 
HIV care cascade.24 In PopART, door-to-door HIV testing 
services increased HIV testing uptake and knowledge of 
HIV status among adolescents aged 15–19 years; 
however, 28% of adolescents were not reached, mainly 
because men and younger age groups were absent 
during household visits.25 HIV self-testing provides a 
crucial opportunity to reach this underserved population.
Our findings suggest that HIV self-testing reached 
previously unreached individuals, including individuals 
previ ously resident in the community but who did not 
Men Women
HIV self-testing Non-HIV 
self-testing
Adjusted odds 
ratio (95% CI)*
p value HIV self-testing Non-HIV 
self-testing
Adjusted odds ratio 
(95% CI)*
p value
Participation in the PopART intervention
Overall 4331/6368 (68%) 4219/6486 (65%) 1·27 (0·99–1·63) 0·06 5959/6899 (86%) 6237/7220 (86%) 1·00 (0·77–1·30) 0·99
Young adults (age 16–29 years) 2281/3129 (73%) 2273/3233 (70%) 1·18 (0·91–1·52) 0·21 3176/3640 (87%) 3297/3769 (88%) 1·04 (0·82–1·33) 0·74
Older adults (age ≥30 years) 2050/3239 (63%) 1946/3253 (60%) 1·29 (0·98–1·69) 0·07 2783/3259 (85%) 2940/3451 (85%) 0·97 (0·71–1·33) 0·86
Resident in PopART annual rounds 1 
and 2, but did not participate in either 
round
148/441 (34%) 105/427 (25%) 1·59 (1·08–2·33) 0·02 64/142 (45%) 54/140 (39%) 1·20 (0·71–2·03) 0·50
Participated in PopART annual 
rounds 1 or 2 or both, but declined 
door-to-door HIV testing
402/656 (61%) 390/665 (59%) 1·26 (0·85–1·87) 0·24 547/688 (80%) 604/760 (80%) 0·99 (0·66–1·48) 0·95
Accepting an offer of HIV testing services among individuals eligible for HIV testing
Overall† 3581/4069 (88%) 3242/3890 (83%) 1·42 (1·10–1·85) 0·01 4496/5271 (85%) 4558/5414 (84%) 1·05 (0·82–1·35) 0·68
Young adults (age 16–29 years) 2063/2253 (92%) 1945/2239 (87%) 1·56 (1·15–2·12) 0·01 2714/3009 (90%) 2731/3090 (88%) 1·29 (0·95–1·74) 0·10
Older adults (age ≥30 years) 1518/1816 (84%) 1297/1651 (79%) 1·44 (1·07–1·94) 0·02 1782/2262 (79%) 1827/2324 (79%) 1·02 (0·79–1·33) 0·85
Resident in PopART annual rounds 1 
and 2, but did not participate in either 
round
122/142 (86%) 83/102 (81%) 1·33 (0·66–2·66) 0·42 43/62 (69%) 26/49 (53%) 1·74 (0·76–3·98) 0·19
Participated in PopART annual rounds 1 
or 2 or both, but declined door-to-door 
HIV testing
276/396 (70%) 223/377 (59%) 1·64 (1·05–2·54) 0·03 300/529 (57%) 327/580 (56%) 1·02 (0·71–1·45) 0·93
Data are n/N (%).*Adjusted for sex, age, community, and clustering by zones. †Three individuals who first used an HIV self-test kit in the absence of a community HIV care provider but later self-reported being 
HIV positive were not included.
Table 4: Participation in the PopART intervention and accepting an offer of HIV testing
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partici pate in two rounds of PopART.9,26 Most individuals 
who self-tested opted for supervised HIV self-testing. 
HIV self-testing probably displaced use of finger-prick 
RDT by some individuals who would have otherwise 
accepted finger-prick HIV-testing services, but the use 
of HIV self-testing was new in these communities and 
testing preferences would probably change over time 
with increased familiarity. The OraQuick HIV self-test 
used in this study has a sensitivity of 95·5% (95% CI 
89·7–98·5) when compared with the Zambian national 
rapid diagnostic test algorithm and is more expensive 
than standard blood-based rapid diagnostic tests.15 Our 
cost analysis showed that the economic cost per HIV 
tester was higher in the HIV self-testing group than in 
the non-HIV self-testing group. As lay counsellors 
become more familiar with offering HIV self-testing 
and communities more aware of HIV self-testing, unit 
costs are likely to decrease with time. Costs of accessing 
harder-to-reach individuals might, however, be higher 
still in settings where there has been little access to 
HIV testing services. In this study setting, many HIV-
positive individuals were reached after 3 years of 
PopART service delivery, and therefore HIV positivity 
in testers was lower than in a population naive to HIV 
testing.
The HIV positivity of supervised HIV self-testing, un-
supervised HIV self-testing, and finger-prick RDT were 
similar. Through secondary distribution, HIV positivity 
was slightly higher than primary HIV self-test kit 
distribution and finger-prick RDT. Although the 
numbers were small, these findings suggest that 
offering HIV self-testing to individuals who are home 
during household visits reaches a similar population as 
finger-prick RDT. Secondary distribution and 
unsupervised HIV self-testing among men, however, 
seems to reach individuals that would have been missed 
had only finger-prick RDT been available. However, 
confirming use of an HIV self-test kit, and measuring 
linkage to care is challenging with unsupervised HIV 
self-testing and secondary distribution. In a Kenyan trial 
of truck drivers, there was no difference in HIV testing 
uptake comparing the choice of finger-prick RDT or 
supervised HIV self-testing with an offer of finger-prick 
RDT.27 However, when including men who took an HIV 
self-testing kit home and self-reported use via the 
telephone, there was evidence that the choice group had 
higher testing uptake.27 In our study, among individuals 
who used a secondary distribution HIV self-test kit and 
for whom community HIV care providers recorded a 
reactive result, more than a third were later seen by the 
community HIV care provider and confirmed HIV 
positive. For many, HIV self-testing is probably 
appealing as it is private and confidential. This benefit, 
however, poses challenges for public health research to 
measure the effect of HIV self-testing on the uptake of 
HIV testing services, linkage to care, or prevention 
services. Novel strategies to measure uptake and 
linkage, or non-financial incentives to encourage return 
of used HIV self-test kits, could be explored in future 
studies.
The expansion of HIV self-testing has been met with 
concerns regarding potential for social harm.11,28 A review 
of studies of HIV self-testing found little published 
evidence of social harms associated with HIV self-
testing.28 We noted little evidence of serious adverse 
events attributable to HIV self-testing in our study. We 
consider this to be because community HIV care 
providers were careful about how they introduced HIV 
self-testing and, in the case of secondary distribution, 
informed individuals to be cautious when introducing 
HIV self-test kits to partners. Further, HIV self-test kits 
were only left for absent partners of individuals aged 
18 years and older. This could, however, also be partly 
due to a reluctance of community members to discuss 
negative social experiences with researchers. The 
occurrence and reporting of less severe social harms, 
such as coerced HIV testing, suggests that developing 
mechanisms for detecting and reporting social harms 
earlier in a study might be beneficial.
Our study had limitations. The HIV self-testing inter-
vention was done in established PopART communities 
where trained community HIV care providers have built 
good rapport with the community and have been providing 
HIV testing services since 2013. This exposure to door-to-
door testing services might have affected uptake of HIV 
self-testing and might limit the generalisability of the 
findings. It is also likely that providing HIV self-test kits in 
this setting increased the costs because a more pragmatic 
approach would be taken in a real-life setting. By its nature, 
an HIV self-test kit is meant to be used in private. As such, 
the results of use of secondary distribution HIV self-test 
kits might have inherent biases. However, we believe 
reporting bias was minimised given the established 
relationships between the community HIV care providers 
and the community. Although blinding of the participants 
was not feasible, performance bias was minimised by 
allocating the community HIV care providers permanently 
to either the HIV self-testing group or the non-HIV self-
testing group throughout the study.
In conclusion, a 3-month intervention of the addition 
of HIV self-testing to door-to-door offer of finger-prick 
RDT had small but significant effects on knowledge of 
HIV status and uptake of HIV testing services in four 
communities in Zambia. This effect was seen among 
men, but also among community residents who pre-
viously declined participation in PopART. Community-
based secondary distribution of HIV self-test kits might 
be an effective strategy to provide HIV testing to reach 
individuals underserved by HIV-testing services in 
settings exposed to door-to-door delivery of HIV-testing 
services. To maximise the effect and reduce costs, any 
future rollout plan should target services more efficiently 
to reach men and other popu lations who are not currently 
accessing available HIV-testing services.
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